哌拉西林/他唑巴坦治疗老年呼吸道感染患者的临床疗效分析

Piperacillin / tazobactam clinical analysis treating elderly patients with respiratory tract infections

目的对哌拉西林/他唑巴坦治疗老年呼吸道感染的临床疗效进行探讨。方法选取该院2013年9月—2014年9月收治的88例老年呼吸道感染患者,随机分成观察组(44例)与对照组(44例),对照组患者给予哌拉西林/舒巴坦治疗,观察组患者给予哌拉西林/他唑巴坦治疗,观察比较两组患者的治疗效果。结果观察组与对照组患者的治疗总有效率分别为95.5%、77.3%,两组比较,差异有统计学意义(P<0.05),且两组患者的不良反应发生率差异无统计学意义(P>0.05)。结论哌拉西林/他唑巴坦对老年呼吸道感染的治疗效果较好,能提高临床治愈率,且安全性较高。

Objective To piperacillin / tazobactam clinical efficacy of the treatment of respiratory tract infections in elderly were discussed. Methods A hospital in September 2013-2014 September 88 elderly patients admitted to the respiratory tract infection were randomly divided into observation group （44 cases） and control group （44 cases） and control group were treated with piperacillin/sulbactam treatment, observation group were treated with piperacillin /tazobactam treatment, the treatment effect was observed between the two groups of patients. Results The treatment group and the control group of patients with total efficiency of 95.5%, 77.3%, respectively, the two groups, the difference was statistically significant （P 〈0.05）, with no statistically significant differences between groups in the incidence of adverse reactions in patients （P〉 0.05）. Conclusions Piperacillin / tazobactam in the treatment of respiratory tract infections in the elderly is better able to improve the clinical cure rate and high security.